文献速递复苏、休克与脓毒症呼吸衰竭与机械通气

急诊科气管插管围插管期心搏骤停的相关危险因素

Risk factors associated with peri-intubation cardiac arrest in the emergency department.
PubMed 文献 · Am J Emerg Med · 2022-06-11
一句话结论急诊插管前低血压(收缩压<90 mmHg)、乳酸性酸中毒及心源性肺水肿为围插管期心搏骤停的独立危险因素。

该回顾性巢式病例对照研究纳入2016年1月1日至2020年12月31日急诊科气管插管的5130例患者,其中92例(1.8%)发生围插管期心搏骤停,按年龄和性别匹配276例对照。插管前收缩压和舒张压更低(104 vs. 136.5 mmHg,p < 0.01;59.5 vs. 78 mmHg,p < 0.01),休克指数更高(0.97 vs. 0.83,p < 0.0001)。多因素分析显示,以心源性肺水肿为插管指征(aOR: 5.921,95% CI: 1.044-33.57,p = 0.04)、插管前收缩压<90 mmHg(aOR: 5.217,95% CI: 1.484-18.34,p = 0.01)及乳酸升高(aOR: 1.012,95% CI: 1.002-1.022,p = 0.01)为独立危险因素。作者认为插管前低血压患者围插管期心搏骤停风险更高,未来需研究插管前复苏的影响及气道管理策略。

要点

  • 插管前收缩压<90 mmHg是围插管期心搏骤停的独立危险因素(aOR: 5.217,95% CI: 1.484-18.34,p = 0.01)。
  • 以心源性肺水肿为插管指征者围插管期心搏骤停风险升高(aOR: 5.921,95% CI: 1.044-33.57,p = 0.04)。
  • 插管前乳酸每升高1单位,围插管期心搏骤停风险增加(aOR: 1.012,95% CI: 1.002-1.022,p = 0.01)。
  • 发生围插管期心搏骤停者插管前收缩压更低(104 vs. 136.5 mmHg,p < 0.01),舒张压更低(59.5 vs. 78 mmHg,p < 0.01)。
  • 发生围插管期心搏骤停者插管前休克指数更高(0.97 vs. 0.83,p < 0.0001)。

适用人群与场景

  • 2016年1月1日至2020年12月31日在急诊科接受气管插管的患者,共5130例符合纳入标准。

诊断标准与关键阈值

  • 围插管期心搏骤停定义:气管插管后发生的围插管期心搏骤停。

红旗征与不能漏的情况

  • 插管前收缩压<90 mmHg(aOR: 5.217,95% CI: 1.484-18.34,p = 0.01)。
  • 以心源性肺水肿为插管指征(aOR: 5.921,95% CI: 1.044-33.57,p = 0.04)。
  • 插管前乳酸升高(aOR: 1.012,95% CI: 1.002-1.022,p = 0.01)。

研究设计与关键结果

  • 研究类型:回顾性巢式病例对照研究,研究期间共6983例患者接受气管插管,5130例符合纳入标准。
  • 围插管期心搏骤停发生率:92例(1.8%)符合围插管期心搏骤停标准,276例按年龄和性别匹配为对照组。
  • 插管前收缩压:心搏骤停组104 mmHg vs. 对照组136.5 mmHg,p < 0.01;舒张压:心搏骤停组59.5 mmHg vs. 对照组78 mmHg,p < 0.01。
  • 插管前休克指数:心搏骤停组0.97 vs. 对照组0.83,p < 0.0001。
  • 独立危险因素:心源性肺水肿为插管指征(aOR: 5.921,95% CI: 1.044-33.57,p = 0.04);插管前收缩压<90 mmHg(aOR: 5.217,95% CI: 1.484-18.34,p = 0.01);乳酸升高(aOR: 1.012,95% CI: 1.002-1.022,p = 0.01)。

证据类型、等级与局限

  • 证据类型:回顾性巢式病例对照研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,插管前低血压患者围插管期心搏骤停风险更高;未来需研究插管前复苏的影响并建立气道管理策略以避免严重并发症。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Peri-intubation cardiac arrest is an uncommon, serious complication following endotracheal intubation in the emergency department. Although several risk factors have been previously identified, this study aimed to comprehensively identify risk factors associated with peri-intubation cardiac arrest.

METHODS: This retrospective, nested case-control study conducted from January 1, 2016 to December 31, 2020 analyzed variables including demographic characteristics, triage, and pre-intubation vital signs, medications, and laboratory data. Univariate analysis and multivariable logistic regression models were used to compare clinical factors between the patients with peri-intubation cardiac arrest and patients without cardiac arrest.

RESULTS: Of the 6983 patients intubated during the study period, 5130 patients met the inclusion criteria; 92 (1.8%) patients met the criteria for peri-intubation cardiac arrest and 276 were age- and sex-matched to the control group. Before intubation, systolic blood pressure and diastolic blood pressure were lower (104 vs. 136.5 mmHg, p < 0.01; 59.5 vs. 78 mmHg, p < 0.01 respectively) and the shock index was higher in the patients with peri-intubation cardiac arrest than the control group (0.97 vs. 0.83, p < 0.0001). Cardiogenic pulmonary edema as an indication for intubation (adjusted odds ratio [aOR]: 5.921, 95% confidence interval [CI]: 1.044-33.57, p = 0.04), systolic blood pressure < 90 mmHg before intubation (aOR: 5.217, 95% CI: 1.484-18.34, p = 0.01), and elevated lactate levels (aOR: 1.012, 95% CI: 1.002-1.022, p = 0.01) were independent risk factors of peri-intubation cardiac arrest.

CONCLUSIONS: Patients with hypotension before intubation have a higher risk of peri-intubation cardiac arrest in the emergency department. Future studies are needed to evaluate the influence of resuscitation before intubation and establish airway management strategies to avoid serious complications.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Yang TH, Chen KF, Gao SY, et al. Risk factors associated with peri-intubation cardiac arrest in the emergency department. Am J Emerg Med. 2022. PMID: 35716536. doi:10.1016/j.ajem.2022.06.013

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。